Increased demand for transdermal drug delivery is expected to drive market expansion in the near future at a CAGR of 5.50% during the forecast period 2024 to 2032.

Market Research Future (MRFR) has published a cooked research report on the “Global Adhesive for Drug Delivery System Market” that contains information from 2019 to 2032. The Adhesive for Drug Delivery System market is estimated to register a CAGR of 5.50% during the forecast period of 2024 to 2032.

MRFR recognizes the following companies as the key players in the global Adhesive for Drug Delivery System market— 3M Company, Henkel AG & Co. KGaA, Avery Dennison Corporation, Scapa Group plc, Dow Inc., AdhexPharma, Corium International, Inc., Lohmann GmbH & Co. KG, ProMed Pharma, Pharmaplast AG, and Others.

Adhesive for Drug Delivery System Market Highlights

The global Adhesive for Drug Delivery System market is accounted to register a CAGR of 5.50% during the forecast period and is estimated to reach USD xx billion by 2032.

The adhesive for drug delivery system market is experiencing growth due to several factors. Firstly, advancements in medical technology have enabled the development of more sophisticated drug delivery systems that require reliable adhesives to ensure proper functionality. Additionally, the increasing prevalence of chronic diseases necessitates long-term drug delivery solutions, further driving the demand for adhesive-based systems. Moreover, the rising geriatric population globally fuels the demand for innovative drug delivery methods, contributing to the growth of this market.

Segment Analysis

The global Adhesive for Drug Delivery System market has been segmented based on Resin Type and Technology.

Based on Resin Type, the market is segmented into Acrylic, Polyisobutylene, Silicone and Others. The acrylic resin type dominated the Adhesive for Drug Delivery System market in 2023 due to its versatility, offering excellent adhesion properties, biocompatibility, and durability. Its compatibility with various drug formulations and substrates, along with its ease of processing, made it the preferred choice for drug delivery applications, driving its market share.

Based on Technology, the global Adhesive for Drug Delivery System market has been segmented into Hydration-Mediation Adhesion, Bonding-Mediation Adhesion, Receptor-Mediation Adhesion, and others. Hydration-mediated adhesion technology led the Adhesive for Drug Delivery System market in 2023 owing to its unique ability to provide strong and reversible adhesion in moist environments like skin. Its compatibility with transdermal and wearable drug delivery systems, coupled with enhanced patient comfort and efficacy, propelled its widespread adoption and market dominance.

Explore In-depth Market Details [Table of Content, List of Figures, List of Tables] of Adhesive for Drug Delivery System Market Research Report

Regional Analysis

The global Adhesive for Drug Delivery System market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World. North America consists of the US and Canada. The Europe Adhesive for Drug Delivery System market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Adhesive for Drug Delivery System market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Adhesive for Drug Delivery System market comprises the Middle East, Africa, and Latin America.

North America dominated the Adhesive for Drug Delivery System market due to several factors. Firstly, the region's robust healthcare infrastructure and significant investments in research and development fostered innovation in drug delivery technologies. Additionally, high healthcare spending and a large patient population with chronic diseases drove the demand for advanced drug delivery systems, contributing to North America's leading market position in this sector.

Europe secured the second-largest market share in the Adhesive for Drug Delivery System market due to factors such as a well-established pharmaceutical industry, extensive research and development activities, and a growing emphasis on patient-centric healthcare delivery. Additionally, favorable government initiatives promoting the adoption of innovative medical technologies, coupled with increasing healthcare expenditure, further fueled the demand for adhesive-based drug delivery systems in the region.

Asia Pacific is experiencing the highest Compound Annual Growth Rate (CAGR) in the Adhesive for Drug Delivery System market due to factors like rapidly expanding healthcare infrastructure, increasing investment in research and development, and a rising prevalence of chronic diseases. Moreover, the region's large and aging population, along with improving access to healthcare, is driving the demand for advanced drug delivery systems, propelling market growth.

Furthermore, the rest of the world's Adhesive for Drug Delivery System market is divided into the Middle East, Africa, and Latin America. The rest of the world is experiencing growth in the Adhesive for Drug Delivery System market due to factors such as increasing healthcare expenditure, rising awareness about advanced medical technologies, and expanding pharmaceutical industries. Additionally, collaborations and partnerships with global players are driving the adoption of adhesive-based drug delivery systems in these regions.

Key Findings of the Study

• The global Adhesive for Drug Delivery System market is expected to reach USD xx billion by 2032, at a CAGR of 5.50% during the forecast period.


• The Asia Pacific region is the fastest-growing in the Adhesive for Drug Delivery System market due to factors such as rapid urbanization, increasing healthcare infrastructure investments, expanding pharmaceutical industry, and growing demand for advanced medical technologies.


• Based on Technology, the Hydration-Mediation Adhesion segment was attributed to holding the largest market in 2023.


• 3M Company, Henkel AG & Co. KGaA, Avery Dennison Corporation, Scapa Group plc, Dow Inc., AdhexPharma, Corium International, Inc., Lohmann GmbH & Co. KG, ProMed Pharma, and Pharmaplast AG are the key market players.